CAS: 1018946-38-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Benzofuran, 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)- REF: AN-AG0005U5CAS: 1018946-38-7 | 98% | To inquire | Tue 07 May 24 |
 | MDR-1339 REF: TM-TQ0026CAS: 1018946-38-7 | 98.57% | 66.00 €~975.00 € | Tue 14 May 24 |
 | DWK-1339 REF: 3D-TQB94638CAS: 1018946-38-7 | Min. 95% | To inquire | Tue 18 Jun 24 |
Benzofuran, 2-(3,4-dimethoxyphenyl)-5-(3-methoxypropyl)-
CAS:1018946-38-7
Formula:
C20H22O4
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
326.3863
Ref: AN-AG0005U5
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 7 May 2024
MDR-1339
CAS:1018946-38-7
MDR-1339 is a blood-brain-barrier-permeable inhibitor of amyloid-β (Aβ) aggregation.
Formula:
C20H22O4
Purity:
98.57%
Color and Shape:
Solid
Molecular weight:
326.39
Ref: TM-TQ0026
| 1mg | 66.00 € | |
| 5mg | 144.00 € | |
| 10mg | 236.00 € | |
| 25mg | 465.00 € | |
| 50mg | 690.00 € | |
| 100mg | 975.00 € | |
| 1ml*10 (DMSO) | 94.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
DWK-1339
CAS:1018946-38-7
DWK-1339 is a benzofuran derivative with pharmacokinetic properties that resemble those of the benzodiazepine class …
Formula:
C20H22O4
Purity:
Min. 95%
Molecular weight:
326.39 g/mol
Ref: 3D-TQB94638
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Jun 2024
